NEW YORK (360Dx) – Clinical Genomics and Quest Diagnostics today announced the US Food and Drug Administration cleared InSure One, a fecal immunochemical test, or FIT, designed to detect blood in stool.

Clinical Genomics manufactures InSure FIT tests, including InSure One, which Quest provides to physicians and organized provider groups, including through specialized programs with accountable care organizations across the US. The companies expect the test to be commercially available in early 2018.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
14

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
19

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.